2026年11月3日星期二
M
Meridian Globe
သတင်းအမြန်
Oriental Kopi founder wants to put Malaysia on the menu— 日经 Nikkei AsiaIndonesian political maneuvers hinder market reforms amid downgrade threats— 日经 Nikkei AsiaChinese Communist Party taps big data surveillance to combat corruption— 日经 Nikkei AsiaJapan is attracting startups. But can it keep them?— 日经 Nikkei AsiaMitsubishi Heavy gears up to boost US gas turbine production— 日经 Nikkei AsiaNuclear reactors under construction rise to 79 globally on AI demand— 日经 Nikkei AsiaMyanmar refugees fill labor gaps in Thailand as Cambodians return home— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei AsiaOriental Kopi founder wants to put Malaysia on the menu— 日经 Nikkei AsiaIndonesian political maneuvers hinder market reforms amid downgrade threats— 日经 Nikkei AsiaChinese Communist Party taps big data surveillance to combat corruption— 日经 Nikkei AsiaJapan is attracting startups. But can it keep them?— 日经 Nikkei AsiaMitsubishi Heavy gears up to boost US gas turbine production— 日经 Nikkei AsiaNuclear reactors under construction rise to 79 globally on AI demand— 日经 Nikkei AsiaMyanmar refugees fill labor gaps in Thailand as Cambodians return home— 日经 Nikkei AsiaCyber insurance inquiries surge at Japan's nonlife insurers— 日经 Nikkei Asia

Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials

ရင်းမြစ် Nature 医学研究လွန်ခဲ့သော 21 နာရီ
Summary

ကျွန်ုပ်တို့သည် ခေါင်းစဉ်နှင့် အနှစ်ချုပ် ညွှန်းကိန်းကိုသာ ပေးသည်။ အပြည့်အစုံနှင့် မူပိုင်ခွင့်သည် မူရင်းထုတ်ဝေသူထံတွင် ရှိသည် — မူရင်းလင့်ကို နှိပ်၍ ဖတ်ပါ။

မူရင်း ဖွင့်ရန်
ကဏ္ဍ
Health
ဒေသ
Global
Language
English
Item ID
health-00a74bed

Comments 0 comments

No comments yet. Be the first.

Povorcitinib for nonsegmental vitiligo: two randomized, controlled, phase 3 STOP-V trials · Meridian Globe